Lisa Glatch - May 24, 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Role: Director
Signature: /s/ Callie Plant, by power of attorney for Lisa Glatch
Stock symbol: XYL
Transactions as of: May 24, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/26/2023, 05:34 PM
Previous filing: Mar 8, 2023
Next filing: Jan 16, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XYL	Common Stock	Award	$0	+1.63K		$0.00	1.63K	May 24, 2023	Direct	F1
transaction	XYL	Common Stock	Award	$0	+5.96K	+365.16%	$0.00	7.6K	May 24, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.
F2	Received in exchange for 12,427 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.

Content

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.

Received in exchange for 12,427 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.